These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 30967630)

  • 1. Pathogenic mutations in neurofibromin identifies a leucine-rich domain regulating glioma cell invasiveness.
    Fadhlullah SFB; Halim NBA; Yeo JYT; Ho RLY; Um P; Ang BT; Tang C; Ng WH; Virshup DM; Ho IAW
    Oncogene; 2019 Jul; 38(27):5367-5380. PubMed ID: 30967630
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ccl5 establishes an autocrine high-grade glioma growth regulatory circuit critical for mesenchymal glioblastoma survival.
    Pan Y; Smithson LJ; Ma Y; Hambardzumyan D; Gutmann DH
    Oncotarget; 2017 May; 8(20):32977-32989. PubMed ID: 28380429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tranilast inhibits the expression of genes related to epithelial-mesenchymal transition and angiogenesis in neurofibromin-deficient cells.
    Harigai R; Sakai S; Nobusue H; Hirose C; Sampetrean O; Minami N; Hata Y; Kasama T; Hirose T; Takenouchi T; Kosaki K; Kishi K; Saya H; Arima Y
    Sci Rep; 2018 Apr; 8(1):6069. PubMed ID: 29666462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CRMP2 Phosphorylation Drives Glioblastoma Cell Proliferation.
    Moutal A; Villa LS; Yeon SK; Householder KT; Park KD; Sirianni RW; Khanna R
    Mol Neurobiol; 2018 May; 55(5):4403-4416. PubMed ID: 28660485
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Identifying the Ubiquitin Ligase complex that regulates the NF1 tumor suppressor and Ras.
    Hollstein PE; Cichowski K
    Cancer Discov; 2013 Aug; 3(8):880-93. PubMed ID: 23661552
    [TBL] [Abstract][Full Text] [Related]  

  • 6.
    Scheer M; Leisz S; Sorge E; Storozhuk O; Prell J; Ho I; Harder A
    Int J Mol Sci; 2021 Dec; 23(1):. PubMed ID: 35008787
    [No Abstract]   [Full Text] [Related]  

  • 7. Schweinfurthin A selectively inhibits proliferation and Rho signaling in glioma and neurofibromatosis type 1 tumor cells in a NF1-GRD-dependent manner.
    Turbyville TJ; Gürsel DB; Tuskan RG; Walrath JC; Lipschultz CA; Lockett SJ; Wiemer DF; Beutler JA; Reilly KM
    Mol Cancer Ther; 2010 May; 9(5):1234-43. PubMed ID: 20442305
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NF1 regulates mesenchymal glioblastoma plasticity and aggressiveness through the AP-1 transcription factor FOSL1.
    Marques C; Unterkircher T; Kroon P; Oldrini B; Izzo A; Dramaretska Y; Ferrarese R; Kling E; Schnell O; Nelander S; Wagner EF; Bakiri L; Gargiulo G; Carro MS; Squatrito M
    Elife; 2021 Aug; 10():. PubMed ID: 34399888
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinicopathologic implications of NF1 gene alterations in diffuse gliomas.
    Vizcaíno MA; Shah S; Eberhart CG; Rodriguez FJ
    Hum Pathol; 2015 Sep; 46(9):1323-30. PubMed ID: 26190195
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MEK Inhibition Enhances the Antitumor Effect of Radiotherapy in NF1-Deficient Glioblastoma.
    Ioannou M; Lalwani K; Ayanlaja AA; Chinnasamy V; Pratilas CA; Schreck KC
    Mol Cancer Ther; 2024 Sep; 23(9):1261-1272. PubMed ID: 38714355
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurofibromin knockdown in glioma cell lines is associated with changes in cytokine and chemokine secretion in vitro.
    Wood MD; Mukherjee J; Pieper RO
    Sci Rep; 2018 Apr; 8(1):5805. PubMed ID: 29643433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Proteasomal and genetic inactivation of the NF1 tumor suppressor in gliomagenesis.
    McGillicuddy LT; Fromm JA; Hollstein PE; Kubek S; Beroukhim R; De Raedt T; Johnson BW; Williams SM; Nghiemphu P; Liau LM; Cloughesy TF; Mischel PS; Parret A; Seiler J; Moldenhauer G; Scheffzek K; Stemmer-Rachamimov AO; Sawyers CL; Brennan C; Messiaen L; Mellinghoff IK; Cichowski K
    Cancer Cell; 2009 Jul; 16(1):44-54. PubMed ID: 19573811
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interaction between a Domain of the Negative Regulator of the Ras-ERK Pathway, SPRED1 Protein, and the GTPase-activating Protein-related Domain of Neurofibromin Is Implicated in Legius Syndrome and Neurofibromatosis Type 1.
    Hirata Y; Brems H; Suzuki M; Kanamori M; Okada M; Morita R; Llano-Rivas I; Ose T; Messiaen L; Legius E; Yoshimura A
    J Biol Chem; 2016 Feb; 291(7):3124-34. PubMed ID: 26635368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurofibromatosis type I tumor suppressor neurofibromin regulates neuronal differentiation via its GTPase-activating protein function toward Ras.
    Yunoue S; Tokuo H; Fukunaga K; Feng L; Ozawa T; Nishi T; Kikuchi A; Hattori S; Kuratsu J; Saya H; Araki N
    J Biol Chem; 2003 Jul; 278(29):26958-69. PubMed ID: 12730209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pathogenic Mutations Associated with Legius Syndrome Modify the Spred1 Surface and Are Involved in Direct Binding to the Ras Inactivator Neurofibromin.
    Führer S; Tollinger M; Dunzendorfer-Matt T
    J Mol Biol; 2019 Sep; 431(19):3889-3899. PubMed ID: 31401120
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A novel neurofibromin (NF1) interaction with the leucine-rich pentatricopeptide repeat motif-containing protein links neurofibromatosis type 1 and the French Canadian variant of Leigh's syndrome in a common molecular complex.
    Arun V; Wiley JC; Kaur H; Kaplan DR; Guha A
    J Neurosci Res; 2013 Apr; 91(4):494-505. PubMed ID: 23361976
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A machine learning classifier trained on cancer transcriptomes detects NF1 inactivation signal in glioblastoma.
    Way GP; Allaway RJ; Bouley SJ; Fadul CE; Sanchez Y; Greene CS
    BMC Genomics; 2017 Feb; 18(1):127. PubMed ID: 28166733
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
    Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
    Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The pre-GAP-related domain of neurofibromin regulates cell migration through the LIM kinase/cofilin pathway.
    Starinsky-Elbaz S; Faigenbloom L; Friedman E; Stein R; Kloog Y
    Mol Cell Neurosci; 2009 Dec; 42(4):278-87. PubMed ID: 19666124
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of neurofibromin Ras-GAP activity enhances the formation of cardiac blood islands in murine embryos.
    Yzaguirre AD; Padmanabhan A; de Groh ED; Engleka KA; Li J; Speck NA; Epstein JA
    Elife; 2015 Oct; 4():e07780. PubMed ID: 26460546
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.